Delivery Order SPE2DB22D3501-SPE2DB25FVL38
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $40,120.55 firm fixed-price delivery order is for the pharmaceutical product KISQALI 400 MG DAILY DOSE 42S. The contract has a period of performance through July 2, 2024 and was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $61,198.26 Firm Fixed Price Delivery Order contract is to provide the pharmaceutical product KISQALI 400 MG DAILY DOSE 42S. The contract has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award is a delivery order valued at $8,605.98, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of KISQALI 400 MG DAILY DOSE 42S, a pharmaceutical product, with a performance period ending on May 16, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is a delivery order worth $11,338.34 awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the drug "KISQALI 200 MG DAILY DOSE UU 21S" and has an ultimate completion date of December 30, 2024. The contract is a firm fixed price arrangement with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,064.52 firm fixed price delivery order is for the supply of 4,568,190,759 units of the prescription medication KISQALI 400 MG DAILY DOSE 42S. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $12,805.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to provide the medication KISQALI 400 MG DAILY DOSE 42S. The contract has a firm fixed price and an ultimate completion date of March 10, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
This federal contract award, valued at $90,600.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,362.48, is for the delivery of the medication KISQALI 600 MG DAILY DOSE 63S. This is a Firm Fixed Price delivery order contract with a completion date of June 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $41,015.16 with a firm fixed price and an ultimate completion date of January 3, 2024. The contract is for the supply of the pharmaceutical product KISQALI 200 MG DAILY DOSE UU 21S. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,555.45 delivery order is for the supply of KISQALI 400 MG DAILY DOSE 42S, a specialty medication. The contract has a firm fixed-price pricing type and an ultimate completion date of December 18, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999...